Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-16-000679
Filing Date
2016-01-26
Accepted
2016-01-26 11:59:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMEND #1 vanda13ga1.htm SC 13G/A 48987
  Complete submission text file 0000935836-16-000679.txt   50489
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Subject) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82196 | Film No.: 161360592
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 250 BEND OR 97709
Business Address 475 GATE FIVE ROAD, SUITE 324 SAUSALITO CA 94965 541.647.5664
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A